Reversible hydrogen spillover at the atomic interface for efficient alkaline hydrogen evolution
Energy & Environmental Science · 2024 · 17 (4) · 1397-1406
DOI: 10.1039/d3ee02760k ↗Kurz gefasst
Fachartikel in der Zeitschrift Energy & Environmental Science, 2024. Verfasst von Tingting Chao und 13 weiteren Autor:innen. Die Arbeit wurde bisher 222-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Basic Research Project of Wenzhou City.
Abstract (Originalsprache)
Ru 1 –Mo 2 C, a novel dual-site synergistic catalyst, demonstrated exceptional performance for the alkaline hydrogen evolution reaction (HER) through a reversible hydrogen spillover mechanism.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Basic Research Project of Wenzhou City
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Chao, T., Xie, W., Hu, Y., Yu, G., Zhao, T., Chen, C., Zhang, Z., Hong, X., Jin, H., Wang, D., Chen, W., Li, X., Hu, P., & Li, Y. (2024). Reversible hydrogen spillover at the atomic interface for efficient alkaline hydrogen evolution. Energy & Environmental Science, 17(4), 1397-1406. https://doi.org/10.1039/d3ee02760k
Vancouver
Chao T, Xie W, Hu Y, Yu G, Zhao T, Chen C, et al. Reversible hydrogen spillover at the atomic interface for efficient alkaline hydrogen evolution. Energy & Environmental Science. 2024;17(4):1397-1406. doi:10.1039/d3ee02760k
BibTeX
@article{Chao2024,
author = {Chao, Tingting and Xie, Wenbo and Hu, Yanmin and Yu, Ge and Zhao, Tonghui and Chen, Cai and Zhang, Zedong and Hong, Xun and Jin, Huile and Wang, Dingsheng and Chen, Wei and Li, Xinhua and Hu, P. and Li, Yadong},
title = {Reversible hydrogen spillover at the atomic interface for efficient alkaline hydrogen evolution},
journal = {Energy & Environmental Science},
year = {2024},
volume = {17},
number = {4},
pages = {1397--1406},
doi = {10.1039/d3ee02760k}
}
EUVIMED